✦ LIBER ✦

P020 CERTOLIZUMAB PEGOL 400 MG EVERY 4 WEEKS IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE IN PRECISE 2

✍ Scribed by B. Feagan; G. Coteur; D. Keininger; S. Schreiber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P022 PATIENTS WITH CROHN'S DISEASE REPOR

✍ B. Feagan; G. Coteur; D. Keininger; S. Schreiber 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 82 KB

Crohn's Disease Patients With Persistent

✍ Sandborn, William J. ;Vermeire, Severine ;Ernault, Etienne ;Lichtenstein, Gary R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 300 KB

PGI4 Health-Related Quality of Life Impr

✍ Hébuterne, X.; †Lémann, M.; Coteur, G.; Ernault, E.; Colombel, J.F. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

143 Welcome: A Randomized, Double-Blind,

✍ William J. Sandborn; Severine Vermeire; Geert R. D'Haens; Jean-Frederic Colombel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB

13 - WELCOME: A randomized, double-blind

✍ W.J. Sandborn; S. Vermeire; G. D'Haens; J.F. Colombel; R.N. Fedorak; M.E. Spehlm 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 62 KB

Certolizumab pegol, a monthly subcutaneo

✍ Paul Rutgeerts; Stefan Schreiber; Brian Feagan; Dorothy L. Keininger; Liz O’Neil 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 250 KB